Salivary interleukin-6 and tumor necrosis factor-α in patients with burning mouth syndrome

Oral Diseases

Volumn 12, Issue 3, 2006, Pages 353-355

  Boras, V Vučićević ^a,d   Brailo, V ^a   Lukac J ^b   Kordic D ^b   Blazic Potocki Z ^c  

^a UNIVERSITY OF ZAGREB   (Croatia)

^b KBC Zagreb   (Croatia)

^c Dental Policlinic   (Croatia)

^d School of Dentistry   (Australia)

Author keywords

Burning mouth syndrome; IL 6; Saliva; TNF

Indexed keywords

INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; AGED; ARTICLE; BURNING MOUTH SYNDROME; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INFLAMMATION; MOUTH MUCOSA; PRIORITY JOURNAL; SALIVA LEVEL; STATISTICAL ANALYSIS; SYMPTOMATOLOGY;

AGED; AGED, 80 AND OVER; BURNING MOUTH SYNDROME; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTERLEUKIN-6; MIDDLE AGED; NEUROGENIC INFLAMMATION; SALIVA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33646676758     PISSN: 1354523X     EISSN: 16010825     Source Type: Journal    
DOI: 10.1111/j.1601-0825.2005.01209.x     Document Type: Article

References (17)

1. Bartoshuk LM Snyder DJ Grushka M Berger AM Duffy VB Kveton JF 2005 Taste damage: previously unsuspected consequences Chem Senses 30 Suppl. 1 i218 i219
2. Bergdahl M Bergdahl J 1999 Burning mouth syndrome: prevalence and associated factors J Oral Pathol Med 28 350 354
3. Femiano F Gombos F Scully C 2004 Burning mouth syndrome: open trial of psychotherapy alone, medication with alpha-lipoic acid (thioctic acid) and combination therapy Med Oral 9 8 13
4. Forssell H Jaaskelainen S Tenovuo O Hinka S 2002 Sensory dysfunction in burning mouth syndrome Pain 99 41 47
5. Hershkovich O Nagler RM 2004 Biochemical analysis of saliva and taste acuity evaluation in patients with burning mouth syndrome, xerostomia and/or gustatory disturbance Arch Oral Biol 49 515 522
6. Jaaskelainen SK Rinne JO Forssel H et al 2001 Role of dopaminergic system in chronic pain-a fluorodopa-PET study Pain 90 257 260
7. Lundy FT Al-Hashimi I Rees TD Lamey PJ 1997 Evaluation of major parotid glycoproteins in patients with burning mouth syndrome Oral Surg Oral Med Oral Pathol Oral Radiol Endod 83 252 258
8. Sardella A Carrassi A 2001 BMS: S for syndrome or s for symptom? A reappraisal of the burning mouth syndrome Minerva Stomatol 50 241 246
9. Savage NW 1996 Burning mouth syndrome: patient management Aust Dent J 41 363 366
10. Scala A Checchi L Montevecchi M Marini I 2003 Update on burning mouth syndrome: overview and patient management Crit Rev Oral Biol Med 14 275 291
11. Tammiala-Salonen T Soderling E 1993 Protein composition, adhesion, and agglutination properties of saliva in burning mouth syndrome Scand J Dent Res 101 215 218
12. Vučićević Boras V Topić B Cekić-Arambašin A Stavljenić-Rukavina A 2001 Levels of salivary IgA, lysozyme and magnesium in patients with burning mouth syndrome and xerostomia Acta Stomatol Croat 2 205 210
13. Vučićević Boras V Čikeš N Lukač J Virag M Cekić-Arambašin A Bošnjak A 2004 The significance of serum and salivary interleukin 6 and basic fibroblast growth factor in patients with Sjögren's syndrome Coll Antro 28 305 311
14. Woda A Pionchon P 1999 A unified concept of idiopathic orofacial pain: clinical features J Orofac Pain 13 172 185
15. World Health Organisation 1997 Oral health surveys. Basic methods 4th edn Geneva WHO
16. Wu-Wang CY Patel M Feng J Milles M Wang SL 1995 Decreased levels of salivary prostaglandin E2 and epidermal growth factor in recurrent aphthous stomatitis Arch Oral Biol 40 1093 1098
17. Xia J Lin M Jin Z 2003 Correlations among mood disorder, serum interleukin-2 and interleukin-6 in patients with burning mouth syndrome Hua Xi Qiang Yi Xue Za Zhi 21 377 378